As reported, the patient underwent placement of a trapease vena cava filter on or about (b)(6) 2003.The trapease filter subsequently malfunctioned and caused injuries and damages to patient including, but not limited to, perforation of patient¿s internal vasculature, dvt and thrombosis of inferior vena cava, and severe and chronic pain.As a direct and proximate result of these malfunctions, the patient has suffered life-threatening injuries and damages, and required extensive medical care and treatment.As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.The product was not returned for analysis.Additionally, as the sterile lot number was not available, device history record review could not be performed. the trapease vena cava filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated.The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart.Dvt, blood clots and thrombosis/occlusion within the ivc does not represent a device malfunction.Clinical factors that may have influenced the event include patient, pharmacological and lesion characteristics.The timing and mechanism of the vessel perforation remains uncertain.The report also included vessel perforation, however the potential cause could not be determined given then information available.Vessel injury is a well-known potential complication for all ivc filter implants and is listed in the instructions for use (ifu) as such.Given the limited information available for review at this time, there is nothing to suggest that the reported event is related to the design and manufacturing process of the device; therefore no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
|
As reported, the patient underwent placement of a trapease vena cava filter on or about (b)(6) 2003.The trapease filter subsequently malfunctioned and caused injuries and damages to patient including, but not limited to, perforation of patient¿s internal vasculature, dvt and thrombosis of inferior vena cava, and severe and chronic pain.As a direct and proximate result of these malfunctions, the patient has suffered life-threatening injuries and damages, and required extensive medical care and treatment.As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.
|